Pattern recognition receptors, such as toll-like receptors and NOD-like receptors, play an important role in recognizing PAMPs and DAMPs, making them key effectors of immunity and excellent anti-inflammatory targets for pharmaceutical drug development.

This meeting will deliver the novel developments and emerging opportunities in targeting pattern recognition receptors for health and disease, including the therapeutic potential for inflammatory diseases and developing opportunities for infectious diseases and cancer.

Presenting Companies:
AC Immune SA | Albert Einstein College of Medicine: Department of Microbiology and Immunology | Beth Israel Deaconess Medical Center | Brunel University: Centre for Infection, Immunity and Disease Mechanisms | Centers for Disease Control and Prevention | Children’s Hospital Boston | Gilead Sciences | Idera Pharmaceuticals | Innate Pharma | Nagasaki University: Department of Molecular Pharmacology and Neuroscience | National Heart & Lung Institute | NovImmune SA | Singapore Immunology Network | University of Alabama at Birmingham | VentiRx Pharmaceuticals | Yale University | And More!